Image

Post Intensive Care Unit Atrial Fibrillation

Post Intensive Care Unit Atrial Fibrillation

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Atrial fibrillation (AF) is a common heart rhythm disorder in the intensive care unit (ICU). It can be precipitated by multiple factors but it is unclear whether AF persists after discharge from the ICU, and long term. This study will investigate whether AF recurs up to one year after ICU discharge.

Description

Atrial fibrillation (AF) is the most common heart rhythm disorder encountered in the intensive care unit (ICU). It can be precipitated by multiple factors present in critically ill patients, such as tissue hypoxia, metabolic disorders etc. There is a paucity of data regarding the persistence of AF in these patients after discharge from the ICU, and in the longer term. Therefore, this study will investigate whether AF recurs up to one year after ICU discharge using an implantable ECG Holter device in adult patients discharged alive from the ICU, with documented new onset AF.

Eligibility

Inclusion Criteria:

  • Age >18 years
  • New onset atrial fibrillation diagnosed in the ICU (12 lead ECG or documented episode of atrial fibrillation lasting at least 30 seconds)
  • Patient hospitalized in the ICU with at least one of the following two criteria:
    • orotracheal intubation for mechanical ventilation
    • AND/OR treatment with amines (vasopressors or inotropic agents)
  • Written informed consent
  • Patient affiliated to a social security regime (or beneficiary thereof)

Exclusion Criteria:

  • Documented history of atrial fibrillation
  • patients admitted to the ICU after cardiothoracic surgery
  • Patients with life expectancy <12 months
  • Patients under legal or judicial protection
  • Patients with no social security coverage
  • Patients within the exclusion period of another clinical trial

Study details
    Atrial Fibrillation
    Critical Illness

NCT05860894

Centre Hospitalier Universitaire de Besancon

16 February 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.